Trial Profile
A multiple-dose study evaluating the pharmacokinetics of 1200 mg once daily and 400 mg twice daily Raltegravir in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 May 2017
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 27 May 2017 New trial record